What is Athletigen Technologies?
Athletigen Technologies operates at the intersection of genetics and athletic performance, offering innovative solutions designed to optimize training and performance through personalized genetic insights. The company targets athletes and fitness enthusiasts seeking to leverage genetic data for enhanced results. This enterprise-level funding suggests Athletigen is moving beyond its initial development phase and is poised for significant scaling and market penetration.
How much funding has Athletigen Technologies raised?
Athletigen Technologies has raised a total of $1.5M across 1 funding round:
Private Equity
$1.5M
Private Equity (2015): $1.5M, investors not publicly disclosed
What's next for Athletigen Technologies?
The substantial enterprise-level funding indicates Athletigen Technologies is entering a critical growth phase. This capital infusion is expected to fuel product development, expand market reach, and potentially drive further innovation in personalized sports genetics. The strategic nature of the recent investment suggests a strong alignment with the investor's objectives, potentially leading to synergistic opportunities and accelerated market adoption.
See full Athletigen Technologies company page
